Daniel G. Bracewell is Professor of Bioprocess Analysis at the UCL Department of Biochemical Engineering. He has made major contributions to fundamentally understanding the recovery of biological products. Generating over £10 million in research funds including collaborations with Thailand, India and the USA. He has authored more than 100 peer reviewed journal articles in the area to date and currently supervises 15 doctoral and postdoctoral projects, many of these studies are in collaboration with industry. One such project was the basis from which the spinout Puridify was created. It was acquired by GE Healthcare (now Cytiva) in 2017.
Our people
Daniel Bracewell
Related news
LCN Academic-Industry Meeting Day 2025
On December 17th, 2025, the LCN hosted an Academic-Industry Meeting Day at Imperial College’s Royal School of Mines. Over 50 attendees, inc…Find out more
New study reports first known use of Positron Emission Particle Tracking (PEPT) in an animal subject
LCN researchers from the School of Biomedical Engineering & Imaging Sciences at King’s College London have published a new study e…Find out more
Lateral thinking: Lateral flow test engineering and lessons learned from COVID-19
A new review paper led by our UCL researchers brings together an international group of world-leading experts to reflect on the lessons lear…Find out more